Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Optimizing Antimicrobial Stewardship (AMS) Interventions and Outcomes in Clinical Outcomes, Optimal Use and Resource UtilizatioRelease Date:Research Inflammation & Immunology China Optimizing Disease Management to Improve Alopecia Areata Quality of CareRelease Date:Quality Improvement Inflammation & Immunology China Research on Exploring Disease Assessment and Prioritizing Systematic Treatment for VitiligoRelease Date:Research Inflammation & Immunology China Quality Improvement in Molecular Testing Pathways for Metastatic Colorectal Cancer (mCRC)Release Date:Partner: American Society for Clinical Pathology (ASCP)Quality Improvement Oncology USA Personalized monitoring&treatment for HR+, HER2- mBC patients treated w CDK4/6i: incorporating Patient complexity risk factorsRelease Date:Quality Improvement, Research Oncology Italy Providing Appropriate Medical Care for IBD PatientsRelease Date:Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)Quality Improvement Inflammation & Immunology Japan Administration of brentuximab vedotin alone or in combination with other approved agents in pre and/or peri CAR-TRelease Date:Research Oncology USA Fostering Educational Initiatives for ALK+ Metastatic Non-Small Cell Lung Cancer(mNSCLC) Tyrosine Kinase Inhibitors(TKI) TherapyRelease Date:Education Oncology Canada Title Grant Type Focus Area Country Application Due Date INNOVAtive Multi-disciplinary Clinical Management of INflammatory Diseases, 2023 IT INNOVA-MINDRelease Date:Quality Improvement Inflammation & Immunology Italy Quality Improvement in Pediatric Endocrinology FieldsRelease Date:Partner: The Japanese Society for Pediatric EndocrinologyQuality Improvement Rare Disease Japan Biomarker Testing / Lung CancerRelease Date:Education Oncology Japan Employment Support / Lung CancerRelease Date:Education Oncology Japan 2023 Oncology FellowshipRelease Date:Fellowship Oncology Canada Approaches to Implement Bispecific Antibodies into Clinical Practice, Increase Awareness and Improve Delivery of Quality of CareRelease Date:Partner: Myeloma CanadaQuality Improvement Oncology Canada Improving Health Equity via Clinical Trial Capability Development in ChinaRelease Date:Education Support for the Professions China Combination Therapy with Relugolix in the Treatment of Advanced Prostate CancerRelease Date:Partner: National Comprehensive Cancer Network; Myovant SciencesResearch Oncology USA Optimizing Women’s Health Conditions in CanadaRelease Date:Quality Improvement Internal Medicine Canada Women’s HealthRelease Date:Education Internal Medicine Canada Accelerating Advancements in Women’s HealthResearch Internal Medicine USA Implementing Rapid Turnaround Time for NGS Molecular Testing for Cancer Patients in Non-Academic and Community CentresRelease Date:Partner: Colorectal Cancer Canada and Thermo Fisher ScientificQuality Improvement Oncology Canada